Recent Updates
Recently added Catalysts
XTNT Positive Sentiment

Xtant Medical Reports First Quarter 2025 Financial Results

Monday, May 12, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Xtant Medical Holdings, Inc. reported a strong financial performance for the first quarter of 2025, with an 18% increase in revenue compared to the previous year. The company achieved positive net income and generated $1.3 million in operating cash flow. Additionally, Xtant raised its revenue guidance for 2025 to a range of $127 million to $131 million.
Price reaction · baseline $0.52 (2025-05-12 close) · hit after-hours · clean, no other XTNT news in the window
day 0 close
+14.7%
day 1
+19.2%
day 3 · peak
+27.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased by 18% year-over-year.
  • The company reported positive net income.
  • Operating cash flow reached $1.3 million.
  • Revenue guidance for 2025 was raised.

Full Press Release Details

Revenue Increases 18% Year-over-Year Delivers Positive Net Income and $1.3 Million in Operating Cash Flow Increases 2025 Revenue Guidance to $127 Million to $131 Million BELGRADE, Mont. , May 12, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical

Frequently Asked Questions

What was Xtant Medical's revenue growth in Q1 2025?

Xtant Medical reported an 18% increase in revenue year-over-year.

Did Xtant Medical achieve positive net income?

Yes, Xtant Medical reported positive net income for the first quarter.

What was the operating cash flow for Xtant Medical?

Xtant Medical generated $1.3 million in operating cash flow.

What is the new revenue guidance for 2025?

Xtant Medical raised its revenue guidance to $127 million to $131 million.

ShareAdd on Google
Tags: XTNT Viatris Investor Conferences Healthcare Xtant Medical financial results revenue growth 2025 guidance
Last updated: May 12, 2025

Biotech snapshot

Cash runway
$10M liquidity · $2M/mo burn
~4 mo
High dilution risk